AdaptHealth (AHCO) Common Equity (2017 - 2026)

AdaptHealth has reported Common Equity for 10 years, with the latest figure at $1.4 billion in Q2 2026.

• On a quarterly basis, Common Equity fell 13.04% year-over-year to $1.4 billion in Q2 2026; TTM through Jun 2026 was $1.4 billion, a 13.04% decrease from a year earlier, with the FY2025 full-year figure at $1.5 billion, down 3.28% from the prior year.
• Common Equity was $1.4 billion for Q2 2026 at AdaptHealth, down from $1.5 billion in the prior quarter.
• The five-year high for Common Equity was $2.2 billion in Q2 2023, with the low at $1.4 billion in Q2 2026.
• Average Common Equity over 5 years is $1.7 billion, with a median of $1.6 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Common Equity gained 18.31% in 2022, then slumped 32.13% in 2024.
• Over 5 years, Common Equity stood at $2.2 billion in 2022, then slumped by 32.03% to $1.5 billion in 2023, then grew by 7.6% to $1.6 billion in 2024, then slipped by 3.28% to $1.5 billion in 2025, then slipped by 9.18% to $1.4 billion in 2026.
• The last three Common Equity figures came in at $1.4 billion (Q2 2026), $1.5 billion (Q1 2026), and $1.5 billion (Q4 2025), per Business Quant data.